Vaccine-induced intestinal immunity to ricin toxin in the absence of secretory IgA

Vaccine

Volumn 29, Issue 4, 2011, Pages 681-689

  Neal, Lori M ^a   McCarthy, Elizabeth A ^a   Morris, Carolyn R ^a   Mantis, Nicholas J ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

Antibody; Biodefense; Mucosal; Toxin; Vaccine

Indexed keywords

IMMUNOGLOBULIN A; RICIN; RICIN VACCINE; RIVAX; SECRETORY COMPONENT; SECRETORY IMMUNOGLOBULIN; TOXOID; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; GENE MUTATION; IMMUNIZATION; INTESTINE MUCOSA; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTITOXINS; FEMALE; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; POISONING; RICIN; VACCINES;

EID: 78650569188     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.11.030     Document Type: Article

References (59)

1. Endo Y., Mitsui K., Motizuki M., Tsurugi K. The mechanism of action of ricin and related toxins on eukaryotic ribosomes. J Biol Chem 1987, 262:5908-5912.
2. Baenziger J.U., Fiete D. Structural determinants of Ricinus communis agglutinin and toxin specificity for oligosaccharides. J Biol Chem 1979, 254(19):9795-9799.
3. Rutenber E., Ready M., Robertus J.D. Structure and evolution of ricin B chain. Nature 1987, 326(6113):624-626.
4. Zentz C., Frenoy J.P., Bourrillon R. Binding of galactose and lactose to ricin. Equilibrium studies. Biochim Biophys Acta 1978, 536(September (1)):18-26.
5. Rapak A., Falnes P.O., Olsnes S. Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol. Proc Natl Acad Sci U S A 1997, 94(April (8)):3783-3788.
6. Sandvig K., Grimmer S., Lauvrak S.U., Torgersen M.L., Skretting G., van Deurs B., et al. Pathways followed by ricin and Shiga toxin into cells. Histochem Cell Biol 2002, 117(2):131-141.
7. Argent R.H., Parrott A.M., Day P.J., Roberts L.M., Stockley P.G., Lord J.M., et al. Ribosome-mediated folding of partially unfolded ricin A-chain. J Biol Chem 2000, 275(March (13)):9263-9269.
8. Spooner R.A., Smith D.C., Easton A.J., Roberts L.M., Lord J.M. Retrograde transport pathways utilised by viruses and protein toxins. Virol J 2006, 3:26.
9. Flexner S. The histological changes produced by ricin and abrin intoxications. J Exp Med 1897, 2:197-220.
10. Ishiguro M., Harada H., Ichiki O., Sekine I., Nishimori I., Kikutani M. Effects of ricin, a protein toxin, on glucose absorption by rat small intestine. (Biochemical studies on oral toxicity of ricin. II). Chem Pharm Bull 1984, 32(8):3141-3147.
11. Ishiguro M., Nakashima H., Tanabe S., Sakakibara R. Interaction of toxic lectin ricin with epithelial cells of rat small intestine in vitro. Chem Pharmaceut Bull 1992, 40(2):441-445.
12. Ishiguro M., Tanabe S., Matori Y., Sakakibara R. Biochemical studies on oral toxicity of ricin. IV. A fate of orally administered ricin in rats. J Pharmacobio-Dynam 1992, 15(4):147-156.
13. Sekine I., Kawase Y., Nishimori I., Mitarai M., Harada H., Ishiguro M., et al. Pathological study on mucosal changes in small intestine of rat by oral administration of ricin. I. Microscopical observation. Acta Pathol Japon 1986, 36(8):1205-1212.
14. Yoder J.M., Aslam R.U., Mantis N.J. Evidence for widespread epithelial damage and coincident production of monocyte chemotactic protein 1 in a murine model of intestinal ricin intoxication. Infect Immun 2007, 75(April (4)):1745-1750.
15. Mantis N.J., McGuinness C.R., Sonuyi O., Edwards G., Farrant S.A. Immunoglobulin A antibodies against ricin A and B subunits protect epithelial cells from ricin intoxication. Infect Immun 2006, 74(June (6)):3455-3462.
16. Jandhyala D.M., Ahluwalia A., Obrig T., Thorpe C.M. ZAK: a MAP3Kinase that transduces Shiga toxin- and ricin-induced proinflammatory cytokine expression. Cell Microbiol 2008, 10(7):1468-1477.
17. Thorpe C.M., Hurley B.P., Lincicome L.L., Jacewicz M.S., Keusch G.T., Acheson D.W. Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells. Infect Immun 1999, 67(11):5985-5993.
18. Thorpe C.M., Smith W.E., Hurley B.P., Acheson D.W. Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression. Infect Immun 2001, 69(10):6140-6147.
19. Yamasaki C., Nishikawa K., Zeng X.T., Katayama Y., Natori Y., Komatsu N., et al. Induction of cytokines by toxins that have an identical RNA N-glycosidase activity: Shiga toxin, ricin, and modeccin. Biochim Biophys Acta 2004, 1671(March (1-3)):44-50.
20. McGuinness C.R., Mantis N.J. Characterization of a novel high-affinity monoclonal immunoglobulin G antibody against the ricin B subunit. Infect Immun 2006, 74(June (6)):3463-3470.
21. Marconescu P.S., Smallshaw J.E., Pop L.M., Ruback S.L., Vitetta E.S. Intradermal administration of RiVax protects mice from mucosal and systemic ricin intoxication. Vaccine 2010, 28(July (32)):5315-5322.
22. Smallshaw J.E., Richardson J.A., Vitetta E.S. RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol. Vaccine 2007, 25(October (42)):7459-7469.
23. Lemley P.V., Amanatides P., Wright D.C. Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo. Hybridoma 1994, 13(5):417-421.
24. Fulton R.J., Uhr J.W., Vitetta E.S. The effect of antibody valency and lysosomotropic amines on the synergy between ricin A chain- and ricin B chain-containing immunotoxins. J Immunol 1986, 136(April (8)):3103-3109.
25. Grimsley G.R., Pace N.C. Spectrophotometric determination of protein concentration. Current protocols in protein science 2003, John Wiley & Sons, Inc., Hoboken (NJ). J.E. Coligan, B.M. Dunn, D.W. Speicher, P.T. Wingfield (Eds.).
26. Koller B.H., Marrack P., Kappler J.W., Smithies O. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science 1990, 248(June (4960)):1227-1230.
27. Burns J.W., Siadat-Pajouh M., Krishnaney A.A., Greenberg H.B. Protective effects of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996, 272:104-107.
28. Michetti P., Mahan M.J., Slauch J.M., Mekalanos J.J., Neutra M.R. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect Immun 1992, 60(5):1786-1792.
29. Peterson D.A., McNulty N.P., Guruge J.L., Gordon J.I. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2007, 2(November (5)):328-339.
30. Silvey K.J., Hutchings A.B., Vajdy M., Petzke M.M., Neutra M.R. Role of immunoglobulin A in protection against reovirus entry into Murine Peyer's patches. J Virol 2001, 75(November (22)):10870-10879.
31. Johansen F.E., Pekna M., Norderhaug I.N., Haneberg B., Hietala M.A., Krajci P., et al. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J Exp Med 1999, 190(7):915-922.
32. Hendrickson B.A., Conner D.A., Ladd D.J., Kendall D., Casanova J.E., Corthesy B., et al. Altered hepatic transport of immunoglobulin A in mice lacking the J chain. J Exp Med 1995, 182(6):1905-1911.
33. Meckelein B., Externest D., Schmidt M.A., Frey A. Contribution of serum immunoglobulin transudate to the antibody immune status of murine intestinal secretions: influence of different sampling procedures. Clin Diagn Lab Immunol 2003, 10(September (5)):831-834.
34. Apter F.M., Lencer W.I., Finkelstein R.A., Mekalanos J.J., Neutra M.R. Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro. Infect Immun 1993, 61(12):5271-5278.
35. Neal L.M., O'Hara J., Brey R.N., Mantis N.J. A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin. Infect Immun 2010, 78(January (1)):552-561.
36. Claypool S.M., Dickinson B.L., Wagner J.S., Johansen F.E., Venu N., Borawski J.A., et al. Bidirectional transepithelial IgG transport by a strongly polarized basolateral membrane Fcgamma-receptor. Mol Biol Cell 2004, 15(April (4)):1746-1759.
37. Rodewald R., Kraehenbuhl J.P. Receptor-mediated transport of IgG. J Cell Biol 1984, 99(1):159S-164S.
38. Yoshida M., Masuda A., Kuo T.T., Kobayashi K., Claypool S.M., Takagawa T., et al. IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity. Springer Semin Immunopathol 2006, 28(December (4)):397-403.
39. Verdin-Teran S.L., Vilches-Flores A., Moreno-Fierros L. Immunization with Cry1Ac from Bacillus thuringiensis increases intestinal IgG response and induces the expression of FcRn in the intestinal epithelium of adult mice. Scand J Immunol 2009, 70(December (6)):596-607.
40. Praetor A., Hunziker W. Beta(2)-microglobulin is important for cell surface expression and pH-dependent IgG binding of human FcRn. J Cell Sci 2002, 115(June (Pt 11)):2389-2397.
41. Zhu X., Meng G., Dickinson B.L., Li X., Mizoguchi E., Miao L., et al. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol 2001, 166(5):3266-3276.
42. Giannasca P.J., Zhang Z.X., Lei W.D., Boden J.A., Giel M.A., Monath T.P., et al. Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters. Infect Immun 1999, 67(February (2)):527-538.
43. Robbins J.B., Schneerson R., Szu S.C. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J Infect Dis 1995, 171(June (6)):1387-1398.
44. Lycke N., Erlandsson L., Ekman L., Schon K., Leanderson T. Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection. J Immunol 1999, 163(July (2)):913-919.
45. Uren T.K., Wijburg O.L., Simmons C., Johansen F.E., Brandtzaeg P., Strugnell R.A. Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies. Eur J Immunol 2005, 35(January (1)):180-188.
46. Belyi Y., Aktories K. Bacterial toxin and effector glycosyltransferases. Biochim Biophys Acta 2010, 1800(February (2)):134-143.
47. Hecht G., Pothoulakis C., LaMont J.T., Madara J.L. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest 1988, 82(November (5)):1516-1524.
48. Hecht G., Koutsouris A., Pothoulakis C., LaMont J.T., Madara J.L. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology 1992, 102(February (2)):416-423.
49. Nusrat A., von Eichel-Streiber C., Turner J.R., Verkade P., Madara J.L., Parkos C.A. Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect Immun 2001, 69(March (30)):1329-1336.
50. Acheson D.W., Moore R., De Breucker S., Lincicome L., Jacewicz M., Skutelsky E., et al. Translocation of Shiga toxin across polarized intestinal cells in tissue culture. Infect Immun 1996, 64(8):3294-3300.
51. Corthier G., Muller M.C., Elmer G.W., Lucas F., Dubos-Ramare F. Interrelationships between digestive proteolytic activities and production and quantitation of toxins in pseudomembranous colitis induced by Clostridium difficile in gnotobiotic mice. Infect Immun 1989, 57(December (12)):3922-3927.
52. Dickinson B.L., Badizadegan K., Wu Z., Ahouse J.C., Zhu X., Simister N.E., et al. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J Clin Invest 1999, 104(October (7)):903-911.
53. Yoshida M., Claypool S.M., Wagner J.S., Mizoguchi E., Mizoguchi A., Roopenian D.C., et al. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 2004, 20(June (6)):769-783.
54. Yoshida M., Kobayashi K., Kuo T.T., Bry L., Glickman J.N., Claypool S.M., et al. Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. J Clin Invest 2006, 116(August (8)):2142-2151.
55. van Deurs B., Hansen S.H., Petersen O.W., Melby E.L., Sandvig K. Endocytosis, intracellular transport and transcytosis of the toxic protein ricin by a polarized epithelium. Eur J Cell Biol 1990, 51(1):96-109.
56. Gonzalez T.V., Farrant S.A., Mantis N.J. Ricin induces IL-8 secretion from human monocyte/macrophages by activating the p38 MAP kinase pathway. Mol Immunol 2006, 43(April (11)):1920-1923.
57. Korcheva V., Wong J., Lindauer M., Jacoby D.B., Iordanov M.S., Magun B. Role of apoptotic signaling pathways in regulation of inflammatory responses to ricin in primary murine macrophages. Mol Immunol 2007, 44(April (10)):2761-2771.
58. Turner J.R. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009, 9(November (11)):799-809.
59. Weber B., Saurer L., Mueller C. Intestinal macrophages: differentiation and involvement in intestinal immunopathologies. Semin Immunopathol 2009, 31(July (2)):171-184.